STOCK TITAN
  1. Home
  2. Sec-filings
  3. CYTK
  4. [Form 4] Cytokinetics Inc. Insider Trading Activity

[Form 4] Cytokinetics Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CYTK logo
Cytokinetics Inc

NASDAQ:CYTK

CYTK Rankings

#1817 Ranked by Market Cap
N/A Ranked by Dividends

CYTK Latest News

Jul 10, 2025
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
Jun 17, 2025
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 10, 2025
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
May 29, 2025
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
May 18, 2025
Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress

CYTK Latest SEC Filings

Jul 16, 2025
[Form 4] Cytokinetics Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Cytokinetics Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Cytokinetics Inc. Insider Trading Activity
Jul 16, 2025
[Form 4] Cytokinetics Inc. Insider Trading Activity
Jul 15, 2025
[Form 4] Cytokinetics Inc. Insider Trading Activity

CYTK Stock Data

4.37B
116.09M
0.45%
114.77%
11.88%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO